Journal Article Summary
The article investigates the effectiveness of donepezil, a medication typically used to treat Alzheimer's disease, in improving cognitive function in breast cancer survivors who experience cognitive impairment after undergoing chemotherapy. This topic is significant because many breast cancer survivors report cognitive issues, often referred to as cancer-related cognitive impairment (CRCI), which can persist long after treatment. As survival rates for breast cancer have improved, understanding and addressing these cognitive challenges has become increasingly important for enhancing the quality of life for survivors.
In this phase 3 clinical trial, 276 adult female breast cancer survivors who had completed chemotherapy 1 to 5 years prior and reported cognitive difficulties were randomly assigned to receive either donepezil or a placebo. The study assessed various cognitive functions, including memory, attention, and executive function, at multiple time points over 36 weeks. The results showed no significant differences in cognitive performance between the donepezil group and the placebo group, indicating that donepezil did not provide the expected benefits in improving memory or other cognitive domains.
The study has several limitations, including a lack of diversity in the participant population, which was predominantly non-Hispanic white women. Additionally, the findings suggest that donepezil may not be an effective treatment for CRCI in this group, raising questions about the appropriateness of this medication for cognitive issues related to cancer treatment. Patients experiencing cognitive difficulties after cancer treatment should discuss these findings with their healthcare providers, who may consider alternative treatments or interventions tailored to their specific needs.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Rapp Stephen R., Dressler Emily V., Brown W. Mark, Wade James L., Le-Lindqwister Nguyet, King David, Rowland Kendrith M., Weaver Kathryn E., et al.. Phase 3 randomized, placebo-controlled clinical trial of donepezil for treatment of cognitive impairment in breast cancer survivors following adjuvant chemotherapy (WF-97116). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2024. DOI: 10.1200/JCO.23.01100. PMID: 38709986. PMCID: PMC11513887.
Featured Pill Pals Product
Donepezil 10 mg Tablets --- Generic For Aricept --- SOLCO
Donepezil 10 mg Tablets — Generic For Aricept — SOLCO is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
